Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Apollo Health Ventures is a transatlantic early-stage venture capital firm founded in 2017, with operations in both Europe and the United States. The firm focuses on co-founding and investing in healthcare companies that target age-related diseases. They manage a portfolio of 11 companies, employing a venture lab approach to foster innovation in biotechnology.
Apollo Health Ventures invests in the biotechnology and healthcare sectors, specifically targeting therapeutics that address the root causes of age-related diseases. Their investment stages range from pre-seed to Series A, with a strategy that includes partnering with scientific experts and research institutions to create new companies.
Notable portfolio companies include Aeovian Pharmaceuticals, Auron Therapeutics, Bloom Science, Booster Therapeutics, Cleara, Focal Biosciences, Galilei, Haya Therapeutics, Ochre Bio, Refoxy Pharma, and Samsara Therapeutics.
Submit your pitch through their form at apollo.vc.
Apollo Health Ventures often co-founds companies, which means they typically lead investment rounds in their portfolio companies.
The firm is open to follow-on investments, particularly in companies that align with their focus on age-related therapeutics and demonstrate significant progress.
Specific fund size details are not disclosed, but the firm actively manages a portfolio of 11 companies across various stages of development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.